MACK - Merrimack Pharmaceuticals Inc
Close
15.13
0 0%
Share volume: 1,255,765
Last Updated: Fri 17 May 2024 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$15.13
0.00
0.00%
Summary score
35%
Profitability
23%
Dept financing
7%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.35%
Return on assets
-16.26%
Return on sales
-56.14%
Return on invested capital
-149.89%
Total debt ratio
100.63%
Debt ratio change over timeo
-1.2%
Current Ratio
4.32%
Quick Ratio
0.67%
Cash Position Ratio
3.12%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.07%
Return on assets
-8.77%
Return on sales
0%
Return on invested capital
31.16%
Total debt ratio
13.7%
Debt ratio change over timeo
-1.19%
Current Ratio
7.03%
Quick Ratio
0%
Cash Position Ratio
6.06%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.7%
Return on assets
-6.02%
Return on sales
0%
Return on invested capital
57.57%
Total debt ratio
11.86%
Debt ratio change over time
-1.92%
Current Ratio
8.29%
Quick Ratio
0%
Cash Position Ratio
6.74%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
6.28%
Return on assets
14.84%
Return on sales
-159.6%
Return on invested capital
4285.14%
Total debt ratio
-119.83%
Debt ratio change over time
-1.2%
Current Ratio
-45.29%
Quick Ratio
-0.04%
Cash Position Ratio
-44.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MACK | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -14.35% | 0% | 0% | 29.06% |
| Return on assets | -16.26% | 0% | 0% | -9.75% |
| Return on sales | -56.14% | 0% | 0% | -1469.44% |
| Return on invested capital | -149.89% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 100.63% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.2% | 0% | 0% | 19.02% |
| Dept financing | 14% | 0% | 0% | 50% |
| Current Ratio | 7.03% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 6.06% | 0% | 0% | 5.68% |
| Liquididy | 48% | 0% | 0% | 73% |
| Short-term ratios | MACK | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -3.07% | 0% | 0% | -16.12% |
| Return on assets | -8.77% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 31.16% | 0% | 0% | 96.56% |
| Profitability | 33% | 0% | 50% | 25% |
| Total debt ratio | 13.7% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.19% | 0% | 0% | 0.09% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 7.03% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 6.06% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 69% |